The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck
Iris Eke, Franziska Leonhardt, Katja Storch et al. · 2009
Read The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck by Iris Eke, Franziska Leonhardt, Katja Storch et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006434.txt.
Description
Iris Eke and colleagues tested a drug against head and neck cancer cells in PLOS ONE in 2009. Cancer cells that resist radiation and drug treatment limit patient survival, so new targets are needed. One candidate target is integrin-linked kinase, a protein many see as druggable. The team studied a small molecule blocker of it called QLT0267.
Their title reports that QLT0267 makes squamous cell carcinoma cells of the head and neck more sensitive to radiation. A drug that primes tumor cells could let radiation work harder at the same dose. The study builds on the group's earlier findings. It points toward combined treatments for hard-to-treat cancers.
Catalog record
| CREATOR | Iris Eke, Franziska Leonhardt, Katja Storch et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006434